US20060085066A1 - Body lumen closure - Google Patents

Body lumen closure Download PDF

Info

Publication number
US20060085066A1
US20060085066A1 US11/296,590 US29659005A US2006085066A1 US 20060085066 A1 US20060085066 A1 US 20060085066A1 US 29659005 A US29659005 A US 29659005A US 2006085066 A1 US2006085066 A1 US 2006085066A1
Authority
US
United States
Prior art keywords
anchoring end
closure device
flexible
strand
expander
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/296,590
Inventor
Sally Thornton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Corp
Original Assignee
Boston Scientific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Corp filed Critical Boston Scientific Corp
Priority to US11/296,590 priority Critical patent/US20060085066A1/en
Publication of US20060085066A1 publication Critical patent/US20060085066A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445Annuloplasty rings in direct contact with the valve annulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B17/0644Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2475Venous valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/068Surgical staplers, e.g. containing multiple staples or clamps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B2017/0649Coils or spirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes

Definitions

  • a venous valve functions to prevent retrograde flow of blood and allow only antegrade flow of blood to the heart.
  • a healthy venous valve 12 is illustrated in a vessel 10 .
  • the valve is bicuspid, with opposed cusps 14 .
  • the cusps 14 are drawn together to prevent retrograde flow (arrow 16 ) of blood.
  • FIG. 1B if the valve is incompetent, the cusps 14 do not seal properly and retrograde flow of blood occurs. Incompetence of a venous valve is thought to arise from at least the following two medical conditions: varicose veins and chronic venous insufficiency.
  • the invention features an implantable medical closure device.
  • the device includes a flexible strand defining an arcuate form.
  • the strand is deformable upon implantation from a large cross-section condition to a small cross-section condition and has at least two anchoring portions disposed along the strand.
  • the anchoring portions are configured to penetrate a wall of a body lumen such that when the strand is deformed to the small cross-section condition, the wall of the body lumen is disposed inwardly.
  • the strand can also be deformable from a second small cross-section condition to the large cross-section condition, for example, the strand may be deformed to the second small cross-section condition to facilitate delivery of the strand to a treatment site, where it is then deformed to the large cross-section condition upon implantation.
  • the strand can include free ends, which free ends can include the anchoring portions of the strand.
  • the strand can define an arc, a helix or can include linear leg portions.
  • the strand can be a filament-form or a band and may be corrugated.
  • the strand can deform from the large cross-section condition to the small cross-section condition by, for example, elastic recovery forces or thermal shape-memory effect.
  • the strand can be formed of metal, for example, nitinol.
  • the anchoring portions of the strand can include, for example, a loop or a barb.
  • the invention features a catheter system, which system includes a catheter for delivery into a lumen.
  • the catheter includes an expander that can be operated between a small cross-section and a large cross-section.
  • the catheter system also includes a closure device positioned about the expander.
  • the closure device is a strand defining an arcuate form and including at least two anchoring portions configured to penetrate a wall of a body lumen.
  • the closure device is deformable by the expander from a first small cross-section condition to a larger cross-section condition to dispose the closure device into engagement with the lumen wall.
  • the closure device is further deformable to a second small cross-section condition, so that the wall of the body lumen is disposed inwardly.
  • the expander can take any convenient form, including, for example, an inflatable balloon, a mechanical expander or a leveraging device.
  • the mechanical expander can include a two-part axial member having a first inner part connected to a first coiled spring and a second outer part connected to a second coiled spring.
  • the closure device is mounted on the first and second coiled springs, and the first inner part of the axial member is rotatable to expand the first coiled spring and the second outer part of the axial member is rotatable to expand the second coiled spring. Expansion of the first and second coiled springs expands the closure device.
  • Each coiled spring can include a distal end configured to fit within a groove formed on either end of the closure device.
  • the leveraging device can include a two-part axial member including a first outer part and a second inner part.
  • a splayed cuff is connected to the distal end of the first outer part of the two-part axial member, and at least two flexible legs are connected to the distal end of the second inner part of the two-part axial member. The legs are flared outwardly to contact the distal end of the splayed cuff.
  • the second inner part of the two-part axial member is moveable toward the splayed cuff such that the flexible legs and the splayed cuff expand radially.
  • the closure device is positioned about the flexible legs and expansion of the flexible legs expands the closure device from a first small cross-section condition to a larger cross-section condition.
  • the second inner part of the two-part axial member is also moveable away from the splayed cuff such that the flexible legs and the splayed cuff retract.
  • the invention features a method of treating a body lumen.
  • the method includes delivering a closure device into a lumen and positioning the strand about the lumen such that a portion of the strand penetrates the wall of the lumen.
  • the method further includes deforming the strand to a smaller cross-section condition such that the wall of the lumen is disposed inwardly.
  • the strand can be positioned about the lumen such that an end of the strand extends through the wall of the lumen.
  • the strand can be disposed on a catheter, which catheter is then delivered into the lumen.
  • the catheter can include an expansion member.
  • Embodiments may have one or more of the following advantages. Closure of a body lumen can be achieved in a minimally invasive manner by delivery of a closure device to a treatment site using a catheter.
  • the closure device may be partially installed within the lumen but configured to minimize profile and thus reduce impedance to the flow of body fluids through the lumen.
  • the amount of lumen closure can be controlled by selecting the size and/or recovery force of the closure device.
  • FIG. 1A is a cross-sectional schematic of a vessel including a competent venous valve
  • FIG. 1B is a schematic of a vessel including an incompetent venous valve.
  • FIG. 2A is a longitudinal cross section of a vessel including a closure device
  • FIG. 2B is a radial cross section of the vessel including the closure device.
  • FIGS. 3A and 3B are longitudinal and radial cross-sectional views, respectively, illustrating delivery of a closure device using a catheter.
  • FIGS. 4A, 4B and 4 C are radial cross-sectional views illustrating implantation of a closure device from within a vessel.
  • FIG. 5 is a schematic view of an embodiment of a closure device.
  • FIG. 6 is a schematic view of an embodiment of a closure device.
  • FIG. 7 is a schematic view of an embodiment of a closure device.
  • FIGS. 8A, 8B and 8 C are radial cross-sectional views illustrating implantation of a closure device from within a vessel.
  • FIG. 9 is a schematic view of an embodiment of a closure device.
  • FIG. 10 is a schematic view of an embodiment of a closure device.
  • FIG. 11 is a schematic view of an embodiment of a closure device.
  • FIGS. 12A, 12B , and 12 D are longitudinal cross-sectional schematic views and FIG. 12C is a radial cross-sectional schematic view illustrating implantation of a closure device from within a vessel.
  • FIGS. 13A, 13B , 13 C, 13 D and 13 E are longitudinal cross-sectional schematic views illustrating implantation of a closure device from within a vessel.
  • FIGS. 14A, 14B and 14 C are longitudinal cross-sectional schematic views illustrating implantation of a closure device from within a vessel.
  • FIGS. 15A, 15B and 15 C are schematic views of an embodiment of a medical device.
  • FIGS. 16A, 16B and 16 C are longitudinal cross-sectional schematic views illustrating implantation of a closure device from within a vessel.
  • a valve closure device 20 is illustrated in position about a vessel 22 at the location of a valve 24 including cusps 26 .
  • the closure device 20 is an arcuate, open-ended, filament-form defining an arc that includes a body 28 which is located in the lumen of the vessel and two anchoring portions 30 which extend into the walls 32 of the vessel.
  • the device 20 provides a force (arrows 34 ) that draws the vessel walls inward, enhancing the function of the valve 24 .
  • the closure device 20 does not substantially impede the flow of blood through the vessel.
  • the body portion 30 is thin and conforms closely to the vessel wall, outside of central portions of the vessel, where flow volume and rate is greatest.
  • the closure device 20 can be positioned at a treatment site in vessel 22 using a catheter 36 , which may be delivered into the vessel percutaneously.
  • the catheter 36 includes a long, flexible body adapted for delivery through the vessel and has near its distal end an expander 38 , such as an inflatable balloon.
  • Suitable balloon catheters include angioplasty balloon catheters and balloon catheters adapted for delivering stents.
  • An example utilizing a coextruded balloon is described in Hamilton et al., U.S. Pat. No. 5,797,877, the entire contents of which is incorporated herein by reference.
  • the catheter may be delivered over a guidewire (not shown).
  • the device 20 may be friction fit over the catheter.
  • a retractable sheath may be used to cover the device and balloon during delivery.
  • the closure device 20 in a radially compacted form, is positioned over the expander 38 in a deflated condition for delivery to the treatment site.
  • the closure device 20 is installed at the treatment site by expanding the expander 38 , i.e. by inflating the balloon.
  • the expander and valve cusps are omitted to more clearly illustrate the installation of the closure device 32 ).
  • the closure device 20 is in a compacted condition as it is carried to the treatment site on the catheter, with the expander in the unexpanded condition.
  • the closure device 20 is sized such that it is smaller than the cross-section of the vessel.
  • the closure device 20 defines an arc that is generally concentric with the arc defined by the vessel wall.
  • the anchoring portions 30 terminate in ends 21 which are oriented along a line 40 , substantially parallel to the center line 44 through the cross-section of the vessel and generally parallel to a tangent 42 , on the blood vessel wall 32 .
  • the device can both stretch axially (arrow 45 ) and deform radially (arrow 46 ) as well as be displaced upwardly (arrow 47 ). The axial stretching does not fully accommodate the expansion.
  • the ends of the filament are deflected such that they are oriented along line 40 , and come into contact with the vessel wall 32 , such that the ends become embedded in the wall.
  • the initial penetration of the ends can be enhanced by rotating the catheter slightly about the catheter axis. Referring to FIG. 4C , as the expander is contracted (i.e. deflated) device 30 begins to contract. The ends 21 further penetrate the wall 32 . As shown the ends may pierce the entire thickness of the wall, and deflect inwardly (arrow 49 ) to contract the vessel.
  • the closure device can be deployed near the base of cusps of an incompetent venous valve, where the cusps meet the wall of the blood vessel. The deployment may be upstream of the cusps. Alternatively, the deployment site can be downstream of the cusps.
  • the catheter is withdrawn through the blood vessel in the same manner the catheter was initially inserted.
  • the closure device may be made of a thin elongate, filament form, such as a metal wire.
  • the metal may be selected such that the device is elastically expandable from the compacted condition for delivery into a lumen to an expanded condition for implantation. Once implanted, elastic recovery of the wire contracts the device and the vessel wall.
  • Suitable metals include elastic steels and superelastic alloy materials such as nitinol.
  • the filament may also be a composite material, such as a composite wire. Superelastic metals and composite wires are described in Heath, U.S. Pat. No. 5,725,570, and Mayer, U.S. Pat. No. 5,800,511, the entire contents of both of which are incorporated herein by reference.
  • the metal may also be a temperature-effect shape memory superelastic alloy that conforms to an implanted condition upon exposure to a controlled temperature, e.g. body temperature.
  • a controlled temperature e.g. body temperature.
  • Suitable shape memory alloys such as nitinol are discussed in Schetsky MacDonald “Shape Memory Alloys,” Encyclopedia of Chemical Technology (3 rd ed) John Wiley and Sons, 1982, vol. 20, p. 726-736.
  • the temperature of the device may be controlled, for example, by heating the expander or by heating the balloon inflation fluid.
  • the wire may also be selected such that the device is plastically deformed from the compacted condition to an expanded condition for embedding the anchoring elements into the vessel wall, with some elastic recovery after the expansion to contract the wall.
  • a mechanical gripper can be used to draw the anchoring portions inward.
  • the filament may also be made of a flexible polymer.
  • the device may be coated with a lubricious polymer or a drug.
  • the anchoring portions may include a tissue sealant to minimize bleeding and enhance vessel wall integrity in the penetration regions.
  • the anchoring portions can also take a number of different forms that permit the ends of the closure device to penetrate the wall of the blood vessel, and restrain the ends from re-entering the vessel.
  • the device 20 is formed of an open-ended strand in the shape of an arc. This shape facilitates deflection of the ends of the strand so that they can be embedded in the vessel wall and also provides a small profile within the vessel, so that blood flow is not substantially impeded.
  • the body of the device, within the vessel closely conforms to the inner wall of the lumen.
  • the closure device 61 can be an open strand defining an arc, which includes ends 64 with anchoring elements 62 , which define loops.
  • the loops defined by the elements 62 prevent the ends 64 of the closure device 61 from reentering the blood vessel and secure the closure device 61 to the wall.
  • the loops can be pressed into the vessel wall on implantation.
  • the ends can be formed of a temperature effect shape memory metal, such that the ends are in a substantially straight condition for implantation but subsequently revert to a loop shape after being embedded in the vessel wall.
  • the closure device 66 can alternatively include ends 68 with anchoring elements 69 configured with barbs, such that the ends 68 can penetrate the wall of the blood vessel and be prevented from reentering the blood vessel by the barbs of the fish hook-like anchoring elements 69 .
  • the closure device can be an open strand 120 having flared ends 122 that terminate in barb elements 123 .
  • the ends 122 can penetrate the wall of the blood vessel and secure the strand 120 to the wall by the curvature of the flared ends 122 .
  • the barb elements are easily pushed into the vessel wall as the device is extended, but resist withdrawal from the wall as the device deflects inwardly.
  • the closure device 70 can be a spiraled open strand to form a loop and a half or more, so that the ends 72 are positioned opposite one another, and include fish hook-like anchoring elements 71 .
  • the closure device 70 is shown in a compacted condition, with the anchoring elements 71 oriented along a tangent line 73 , which is substantially parallel to the center line 75 through the cross-section of the blood vessel, and parallel to a tangent 74 , on the blood vessel wall.
  • the strand can both stretch axially (arrow 78 ) and deform radially (arrow 79 ).
  • the axial stretch does not fully accommodate the expansion.
  • the free ends 72 of the strand are deflected such that the tangent line 73 defines an angle ⁇ with respect to the tangent 74 on the vessel wall and thus penetrates the vessel wall.
  • the ends 72 of the strand further penetrate the wall and deflect inwardly to contract the wall.
  • the closure device 76 can be a spiraled open strand to form a loop and a half, so that the ends 72 are positioned opposite one another, and include anchoring elements 77 defining loops. Implantation of this device would be similar to implantation of the device shown in FIG. 8 , as described above.
  • the closure device 80 can be a strand in the shape of a thin, flat slotted band including three (or more) anchoring elements 60 .
  • the slotted band 80 can include an upper band 65 , middle band 63 and lower band 67 , where the upper band 65 and lower band 67 each include an anchoring element 60 on their distal ends on an opposite side of the band 80 from an anchoring element 60 formed at the distal end of the middle band 63 .
  • Expansion of the closure device 80 by an expansion device causes the anchoring elements 60 to penetrate the vessel wall.
  • the band 80 attempts to contract to the smaller condition and, because the band 80 is secured to the vessel wall, contracts the cross-section of the vessel.
  • the closure device can be a closed, corrugated band 82 .
  • the band 82 includes anchoring elements 83 projecting from the exterior surface of the band. As the band 82 is expanded, the anchoring elements 83 penetrate the wall of the blood vessel.
  • the anchoring elements 83 can be configured such that they lie flat while being transported through the vessel, and are caused to protrude from the band 82 by the expansion of the band 82 using an expansion device. When the expansion device is contracted, the band 82 attempts to contract to a smaller condition, and the anchoring elements 83 cause the cross-section of the vessel to contract.
  • the closure device can be a helical winding 85 having two or more anchoring portions 86 and having any number of helical turns, for example three turns as shown.
  • the helical winding 85 can be transported to the treatment site within a vessel 31 using a catheter 88 having an expander 87 on the distal end. The treatment site is in close proximity to an incompetent venous valve 24 .
  • the helical winding 85 is mounted to the exterior of the expander 87 and can be held in place by any convenient manner, including, for example, a friction fit.
  • a protective sheath 89 can cover the expander 87 and helical winding 85 during transport and be removed once the treatment site is reached.
  • the expander 87 is expanded and thereby expands the helical winding 85 from a small condition to a larger condition.
  • the expander 87 is expanded until the anchoring portions 86 of the helical winding 85 penetrate the wall 44 of the vessel 31 and secure the helical winding 85 to the interior of the vessel 31 .
  • the helical winding 85 can have three anchoring portions 86 as shown in FIG. 12C , or more or less anchoring portions.
  • the expander 87 is then contracted and the catheter 88 removed from the vessel 31 , for example, in the same manner the catheter 88 was deployed.
  • the helical winding 85 tends to contract to the small condition, for example, due to elastic restoring forces or temperature-effect shape memory effect, thereby pulling the sides of the wall 44 inwardly and contracting the cross-sectional area of the vessel 31 .
  • the cusps 38 of the valve 24 are pulled together so that the valve 24 can function competently to prevent antegrade flow within the vessel 31 .
  • the closure device can be a helical winding 94 that is positioned about the exterior of a vessel 31 in the vicinity of an incompetent venous valve 24 .
  • a catheter 90 having an expander 93 on the distal end is transported to a treatment site with the expander 93 in a contracted state.
  • the treatment site is at or near the incompetent venous valve 24 .
  • the catheter 90 includes a lumen 91 having an opening 92 at or near the base of the expander 93 .
  • the expander 93 is expanded to at least the interior dimension of the vessel 31 .
  • the helical winding 94 is formed of a shape-memory material and is passed through the catheter lumen 91 in a substantially straight position, as shown in FIG. 13C .
  • the helical winding 94 is pushed through the opening 92 , which opening 92 is configured such that the winding 94 is directed toward the wall 44 of the vessel 31 .
  • the winding 94 penetrates and is pushed through the wall 44 .
  • the shape-memory effect causes the winding 94 to revert to a helix as the winding is pushed from the catheter lumen 91 , and rides along the outside of the vessel 31 .
  • the expander 93 is contracted and the catheter 90 is withdrawn from the vessel.
  • the helical winding 94 is configured so that when the shape-memory effect causes the winding to revert to a helix, the helical winding 94 pulls the wall 44 of the vessel 31 inwardly, causing the cusps 38 to pull together so that the valve can function competently.
  • the winding 94 can be held in place by friction.
  • the closure device 100 can be an angular hinge-form with at least two linear legs 102 .
  • the closure device 100 can be transported in a compressed condition to a deployment site in the blood vessel by a delivery catheter 103 having a housing 105 for containing the closure device 100 in the compressed condition until the deployment site is reached.
  • the device 100 can be pushed out of the housing 105 by the distal end of the catheter, which can be temporarily connected to the device 100 , for example, by a threaded connection.
  • FIG. 14B the device 100 will naturally expand upon being released from the confines of the housing 105 .
  • An expansion device 106 such as an inflatable balloon, on the distal end of the catheter 103 can be inflated to further expand the closure device 100 by spreading the legs 102 until the anchoring elements 104 penetrate the wall 44 of the blood vessel 41 .
  • the device 100 is then pulled in the direction of the catheter by the distal end of the catheter, which is still connected to the device 100 . This movement causes the anchoring elements 104 to fully penetrate the wall of the blood vessel, and secure the device 100 to the vessel.
  • the catheter is disconnected from the device 100 and removed from the vessel.
  • the device 100 attempts to contract to a smaller condition, thus causing the cross section of the blood vessel to contract.
  • the expander can be a mechanical expander 135 including at least two coiled springs 128 , 129 and having a two-part axial member including an outer tube 133 and an inner rod 134 .
  • the inner rod 134 is affixed to a first coil 129 and can rotate independently of the outer tube 133 , which is affixed to a second coil 128 .
  • the mechanical expander 135 is used in conjunction with a closure device 125 configured to mount about the coils 128 , 129 .
  • Each coil 128 , 129 has an end 130 , 131 configured to fit within a groove 127 formed on either end of the closure device 125 .
  • the coils 128 , 129 and closure device 125 are held together while the expansion device is transported to a treatment site.
  • the mechanical expander 135 is expanded to expand the closure device 125 , thereby causing the anchoring portions 126 of the closure device 125 to penetrate a vessel wall, in a similar manner as described above.
  • the mechanical expander 135 expands by rotating the inner rod 134 to expand the first coil 129 and rotating the outer tube 133 to expand the second coil 128 .
  • the coils 128 , 129 expand radially in opposite directions, exerting a radial force on the closure device 125 , causing the anchoring portions 126 to penetrate a vessel wall.
  • the mechanical expander 135 can be disengaged from the closure device 125 by sliding the mechanical expander 135 axially away from the closure device 125 .
  • the mechanical expander 135 is contracted by rotating the inner rod and outer tube in the opposite directions used for expansion, and is withdrawn from the vessel.
  • a retractable sheath can enclose the mechanical expander 135 and closure device 125 while positioning the assembly at the treatment site, which sheath is then retracted.
  • the expander can be a leveraging device 112 having at least two flexible legs 114 , an axial member 115 and a splayed cuff 116 .
  • a closure device 117 can be mounted onto the exterior of the legs 114 .
  • the axial member 115 can be pulled causing the legs 114 to press against the cuff 116 .
  • the force of the flexible legs 114 against the splayed cuff 116 causes the flexible legs 114 to expand outwardly and the splayed cuff 116 to fan out.
  • the expansion of the circumference around the flexible legs 114 causes the closure device 117 to expand and anchor to the wall of the blood vessel 31 , as described above.
  • the axial member 115 is pushed to release the pressure on the flexible legs 114 , causing them to revert back to the original compressed condition. Similarly, with the force on the splayed cuff 116 removed, the cuff 116 recovers to the original state. The expansion device can then be retracted from the vessel.
  • a closure device may be used to treat vascular vessels at locations without a valve to constrict the vessel at a desired location and other body lumens outside the vascular system.

Abstract

Method and apparatus implementing and using techniques for body lumen closure, including use of an implantable medical closure device. The device includes a flexible strand defining an arcuate form. The strand is deformable upon implantation from a large cross-section condition to a small cross-section condition and has at least two anchoring portions disposed along the strand. The anchoring portions are configured to penetrate a wall of a body lumen such that when the strand is deformed to the small cross-section condition, the wall of the body lumen is disposed inwardly.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 10/115,552, filed Apr. 3, 2002, the specification of which is incorporated herein by reference.
  • BACKGROUND
  • A venous valve functions to prevent retrograde flow of blood and allow only antegrade flow of blood to the heart. Referring to FIG. 1A, a healthy venous valve 12 is illustrated in a vessel 10. The valve is bicuspid, with opposed cusps 14. In the closed condition, the cusps 14 are drawn together to prevent retrograde flow (arrow 16) of blood. Referring to FIG. 1B, if the valve is incompetent, the cusps 14 do not seal properly and retrograde flow of blood occurs. Incompetence of a venous valve is thought to arise from at least the following two medical conditions: varicose veins and chronic venous insufficiency.
  • SUMMARY
  • In a first aspect, the invention features an implantable medical closure device. The device includes a flexible strand defining an arcuate form. The strand is deformable upon implantation from a large cross-section condition to a small cross-section condition and has at least two anchoring portions disposed along the strand. The anchoring portions are configured to penetrate a wall of a body lumen such that when the strand is deformed to the small cross-section condition, the wall of the body lumen is disposed inwardly.
  • The strand can also be deformable from a second small cross-section condition to the large cross-section condition, for example, the strand may be deformed to the second small cross-section condition to facilitate delivery of the strand to a treatment site, where it is then deformed to the large cross-section condition upon implantation. The strand can include free ends, which free ends can include the anchoring portions of the strand. The strand can define an arc, a helix or can include linear leg portions. The strand can be a filament-form or a band and may be corrugated. The strand can deform from the large cross-section condition to the small cross-section condition by, for example, elastic recovery forces or thermal shape-memory effect. The strand can be formed of metal, for example, nitinol. The anchoring portions of the strand can include, for example, a loop or a barb.
  • In another aspect, the invention features a catheter system, which system includes a catheter for delivery into a lumen. The catheter includes an expander that can be operated between a small cross-section and a large cross-section. The catheter system also includes a closure device positioned about the expander. The closure device is a strand defining an arcuate form and including at least two anchoring portions configured to penetrate a wall of a body lumen. The closure device is deformable by the expander from a first small cross-section condition to a larger cross-section condition to dispose the closure device into engagement with the lumen wall. The closure device is further deformable to a second small cross-section condition, so that the wall of the body lumen is disposed inwardly.
  • The expander can take any convenient form, including, for example, an inflatable balloon, a mechanical expander or a leveraging device. The mechanical expander can include a two-part axial member having a first inner part connected to a first coiled spring and a second outer part connected to a second coiled spring. The closure device is mounted on the first and second coiled springs, and the first inner part of the axial member is rotatable to expand the first coiled spring and the second outer part of the axial member is rotatable to expand the second coiled spring. Expansion of the first and second coiled springs expands the closure device. Each coiled spring can include a distal end configured to fit within a groove formed on either end of the closure device.
  • The leveraging device can include a two-part axial member including a first outer part and a second inner part. A splayed cuff is connected to the distal end of the first outer part of the two-part axial member, and at least two flexible legs are connected to the distal end of the second inner part of the two-part axial member. The legs are flared outwardly to contact the distal end of the splayed cuff. The second inner part of the two-part axial member is moveable toward the splayed cuff such that the flexible legs and the splayed cuff expand radially. The closure device is positioned about the flexible legs and expansion of the flexible legs expands the closure device from a first small cross-section condition to a larger cross-section condition. The second inner part of the two-part axial member is also moveable away from the splayed cuff such that the flexible legs and the splayed cuff retract.
  • In another aspect, the invention features a method of treating a body lumen. The method includes delivering a closure device into a lumen and positioning the strand about the lumen such that a portion of the strand penetrates the wall of the lumen. The method further includes deforming the strand to a smaller cross-section condition such that the wall of the lumen is disposed inwardly. The strand can be positioned about the lumen such that an end of the strand extends through the wall of the lumen. The strand can be disposed on a catheter, which catheter is then delivered into the lumen. The catheter can include an expansion member.
  • Embodiments may have one or more of the following advantages. Closure of a body lumen can be achieved in a minimally invasive manner by delivery of a closure device to a treatment site using a catheter. The closure device may be partially installed within the lumen but configured to minimize profile and thus reduce impedance to the flow of body fluids through the lumen. The amount of lumen closure can be controlled by selecting the size and/or recovery force of the closure device.
  • The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
  • DESCRIPTION OF DRAWINGS
  • FIG. 1A is a cross-sectional schematic of a vessel including a competent venous valve, while FIG. 1B is a schematic of a vessel including an incompetent venous valve.
  • FIG. 2A is a longitudinal cross section of a vessel including a closure device, while FIG. 2B is a radial cross section of the vessel including the closure device.
  • FIGS. 3A and 3B are longitudinal and radial cross-sectional views, respectively, illustrating delivery of a closure device using a catheter.
  • FIGS. 4A, 4B and 4C are radial cross-sectional views illustrating implantation of a closure device from within a vessel.
  • FIG. 5 is a schematic view of an embodiment of a closure device.
  • FIG. 6 is a schematic view of an embodiment of a closure device.
  • FIG. 7 is a schematic view of an embodiment of a closure device.
  • FIGS. 8A, 8B and 8C are radial cross-sectional views illustrating implantation of a closure device from within a vessel.
  • FIG. 9 is a schematic view of an embodiment of a closure device.
  • FIG. 10 is a schematic view of an embodiment of a closure device.
  • FIG. 11 is a schematic view of an embodiment of a closure device.
  • FIGS. 12A, 12B, and 12D are longitudinal cross-sectional schematic views and FIG. 12C is a radial cross-sectional schematic view illustrating implantation of a closure device from within a vessel.
  • FIGS. 13A, 13B, 13C, 13D and 13E are longitudinal cross-sectional schematic views illustrating implantation of a closure device from within a vessel.
  • FIGS. 14A, 14B and 14C are longitudinal cross-sectional schematic views illustrating implantation of a closure device from within a vessel.
  • FIGS. 15A, 15B and 15C are schematic views of an embodiment of a medical device.
  • FIGS. 16A, 16B and 16C are longitudinal cross-sectional schematic views illustrating implantation of a closure device from within a vessel.
  • Like reference symbols in the various drawings indicate like elements.
  • DETAILED DESCRIPTION
  • Referring to FIGS. 2A and 2B, a valve closure device 20 is illustrated in position about a vessel 22 at the location of a valve 24 including cusps 26. The closure device 20 is an arcuate, open-ended, filament-form defining an arc that includes a body 28 which is located in the lumen of the vessel and two anchoring portions 30 which extend into the walls 32 of the vessel. The device 20 provides a force (arrows 34) that draws the vessel walls inward, enhancing the function of the valve 24. As evident, the closure device 20 does not substantially impede the flow of blood through the vessel. The body portion 30 is thin and conforms closely to the vessel wall, outside of central portions of the vessel, where flow volume and rate is greatest.
  • Referring to FIGS. 3A and 3B, the closure device 20 can be positioned at a treatment site in vessel 22 using a catheter 36, which may be delivered into the vessel percutaneously. The catheter 36 includes a long, flexible body adapted for delivery through the vessel and has near its distal end an expander 38, such as an inflatable balloon. Suitable balloon catheters include angioplasty balloon catheters and balloon catheters adapted for delivering stents. An example utilizing a coextruded balloon is described in Hamilton et al., U.S. Pat. No. 5,797,877, the entire contents of which is incorporated herein by reference. The catheter may be delivered over a guidewire (not shown). The device 20 may be friction fit over the catheter. A retractable sheath may be used to cover the device and balloon during delivery.
  • The closure device 20, in a radially compacted form, is positioned over the expander 38 in a deflated condition for delivery to the treatment site. Referring as well to FIGS. 4A-4C, the closure device 20 is installed at the treatment site by expanding the expander 38, i.e. by inflating the balloon. (In FIGS. 4A-4C, the expander and valve cusps are omitted to more clearly illustrate the installation of the closure device 32). Referring particularly to FIG. 4A, the closure device 20 is in a compacted condition as it is carried to the treatment site on the catheter, with the expander in the unexpanded condition. The closure device 20 is sized such that it is smaller than the cross-section of the vessel. In the embodiment illustrated, the closure device 20 defines an arc that is generally concentric with the arc defined by the vessel wall. In this condition, the anchoring portions 30 terminate in ends 21 which are oriented along a line 40, substantially parallel to the center line 44 through the cross-section of the vessel and generally parallel to a tangent 42, on the blood vessel wall 32. Referring particularly to FIG. 4B, as the closure device 20 is expanded, the device can both stretch axially (arrow 45) and deform radially (arrow 46) as well as be displaced upwardly (arrow 47). The axial stretching does not fully accommodate the expansion. As a result, the ends of the filament are deflected such that they are oriented along line 40, and come into contact with the vessel wall 32, such that the ends become embedded in the wall. The initial penetration of the ends can be enhanced by rotating the catheter slightly about the catheter axis. Referring to FIG. 4C, as the expander is contracted (i.e. deflated) device 30 begins to contract. The ends 21 further penetrate the wall 32. As shown the ends may pierce the entire thickness of the wall, and deflect inwardly (arrow 49) to contract the vessel. The closure device can be deployed near the base of cusps of an incompetent venous valve, where the cusps meet the wall of the blood vessel. The deployment may be upstream of the cusps. Alternatively, the deployment site can be downstream of the cusps. The catheter is withdrawn through the blood vessel in the same manner the catheter was initially inserted.
  • The closure device may be made of a thin elongate, filament form, such as a metal wire. The metal may be selected such that the device is elastically expandable from the compacted condition for delivery into a lumen to an expanded condition for implantation. Once implanted, elastic recovery of the wire contracts the device and the vessel wall. Suitable metals include elastic steels and superelastic alloy materials such as nitinol. The filament may also be a composite material, such as a composite wire. Superelastic metals and composite wires are described in Heath, U.S. Pat. No. 5,725,570, and Mayer, U.S. Pat. No. 5,800,511, the entire contents of both of which are incorporated herein by reference. The metal may also be a temperature-effect shape memory superelastic alloy that conforms to an implanted condition upon exposure to a controlled temperature, e.g. body temperature. Suitable shape memory alloys such as nitinol are discussed in Schetsky MacDonald “Shape Memory Alloys,” Encyclopedia of Chemical Technology (3rd ed) John Wiley and Sons, 1982, vol. 20, p. 726-736. The temperature of the device may be controlled, for example, by heating the expander or by heating the balloon inflation fluid. The wire may also be selected such that the device is plastically deformed from the compacted condition to an expanded condition for embedding the anchoring elements into the vessel wall, with some elastic recovery after the expansion to contract the wall. Alternatively, a mechanical gripper can be used to draw the anchoring portions inward. The filament may also be made of a flexible polymer. The device may be coated with a lubricious polymer or a drug. For example, the anchoring portions may include a tissue sealant to minimize bleeding and enhance vessel wall integrity in the penetration regions.
  • The anchoring portions can also take a number of different forms that permit the ends of the closure device to penetrate the wall of the blood vessel, and restrain the ends from re-entering the vessel. In the embodiment illustrated above, the device 20 is formed of an open-ended strand in the shape of an arc. This shape facilitates deflection of the ends of the strand so that they can be embedded in the vessel wall and also provides a small profile within the vessel, so that blood flow is not substantially impeded. As illustrated above, the body of the device, within the vessel, closely conforms to the inner wall of the lumen.
  • Referring to FIG. 5, in another embodiment, the closure device 61 can be an open strand defining an arc, which includes ends 64 with anchoring elements 62, which define loops. Once the anchoring elements 62 are positioned on the exterior of the blood vessel, the loops defined by the elements 62 prevent the ends 64 of the closure device 61 from reentering the blood vessel and secure the closure device 61 to the wall. The loops can be pressed into the vessel wall on implantation. Alternatively, the ends can be formed of a temperature effect shape memory metal, such that the ends are in a substantially straight condition for implantation but subsequently revert to a loop shape after being embedded in the vessel wall.
  • Referring to FIG. 6, the closure device 66 can alternatively include ends 68 with anchoring elements 69 configured with barbs, such that the ends 68 can penetrate the wall of the blood vessel and be prevented from reentering the blood vessel by the barbs of the fish hook-like anchoring elements 69.
  • Referring to FIG. 7, the closure device can be an open strand 120 having flared ends 122 that terminate in barb elements 123. The ends 122 can penetrate the wall of the blood vessel and secure the strand 120 to the wall by the curvature of the flared ends 122. The barb elements are easily pushed into the vessel wall as the device is extended, but resist withdrawal from the wall as the device deflects inwardly.
  • As shown in FIGS. 8A-8C, the closure device 70 can be a spiraled open strand to form a loop and a half or more, so that the ends 72 are positioned opposite one another, and include fish hook-like anchoring elements 71. Referring particularly to FIG. 8A, the closure device 70 is shown in a compacted condition, with the anchoring elements 71 oriented along a tangent line 73, which is substantially parallel to the center line 75 through the cross-section of the blood vessel, and parallel to a tangent 74, on the blood vessel wall. Referring particularly to FIG. 8B, as the closure device 70 is expanded by the expansion device (not shown), the strand can both stretch axially (arrow 78) and deform radially (arrow 79). The axial stretch does not fully accommodate the expansion. As a result, the free ends 72 of the strand are deflected such that the tangent line 73 defines an angle θ with respect to the tangent 74 on the vessel wall and thus penetrates the vessel wall. Referring to FIG. 8C, as the device 70 begins to contract, the ends 72 of the strand further penetrate the wall and deflect inwardly to contract the wall.
  • Referring to FIG. 9, the closure device 76 can be a spiraled open strand to form a loop and a half, so that the ends 72 are positioned opposite one another, and include anchoring elements 77 defining loops. Implantation of this device would be similar to implantation of the device shown in FIG. 8, as described above.
  • Referring to FIG. 10, the closure device 80 can be a strand in the shape of a thin, flat slotted band including three (or more) anchoring elements 60. The slotted band 80 can include an upper band 65, middle band 63 and lower band 67, where the upper band 65 and lower band 67 each include an anchoring element 60 on their distal ends on an opposite side of the band 80 from an anchoring element 60 formed at the distal end of the middle band 63. Expansion of the closure device 80 by an expansion device causes the anchoring elements 60 to penetrate the vessel wall. Upon contracting the expansion device, the band 80 attempts to contract to the smaller condition and, because the band 80 is secured to the vessel wall, contracts the cross-section of the vessel.
  • Referring to FIG. 11, in another embodiment, the closure device can be a closed, corrugated band 82. The band 82 includes anchoring elements 83 projecting from the exterior surface of the band. As the band 82 is expanded, the anchoring elements 83 penetrate the wall of the blood vessel. The anchoring elements 83 can be configured such that they lie flat while being transported through the vessel, and are caused to protrude from the band 82 by the expansion of the band 82 using an expansion device. When the expansion device is contracted, the band 82 attempts to contract to a smaller condition, and the anchoring elements 83 cause the cross-section of the vessel to contract.
  • Referring to FIGS. 12A-12D, the closure device can be a helical winding 85 having two or more anchoring portions 86 and having any number of helical turns, for example three turns as shown. Referring to FIG. 12A, the helical winding 85 can be transported to the treatment site within a vessel 31 using a catheter 88 having an expander 87 on the distal end. The treatment site is in close proximity to an incompetent venous valve 24. The helical winding 85 is mounted to the exterior of the expander 87 and can be held in place by any convenient manner, including, for example, a friction fit. Optionally, a protective sheath 89 can cover the expander 87 and helical winding 85 during transport and be removed once the treatment site is reached. Referring to FIG. 12B, the expander 87 is expanded and thereby expands the helical winding 85 from a small condition to a larger condition. The expander 87 is expanded until the anchoring portions 86 of the helical winding 85 penetrate the wall 44 of the vessel 31 and secure the helical winding 85 to the interior of the vessel 31. The helical winding 85 can have three anchoring portions 86 as shown in FIG. 12C, or more or less anchoring portions. The expander 87 is then contracted and the catheter 88 removed from the vessel 31, for example, in the same manner the catheter 88 was deployed. Referring to FIG. 12D, with the expander 87 no longer exerting pressure on the helical winding 85, the helical winding 85 tends to contract to the small condition, for example, due to elastic restoring forces or temperature-effect shape memory effect, thereby pulling the sides of the wall 44 inwardly and contracting the cross-sectional area of the vessel 31. With the helical winding 85 in place within the vessel 31, the cusps 38 of the valve 24 are pulled together so that the valve 24 can function competently to prevent antegrade flow within the vessel 31.
  • Referring to FIGS. 13A-13E, the closure device can be a helical winding 94 that is positioned about the exterior of a vessel 31 in the vicinity of an incompetent venous valve 24. Referring to FIG. 13A, a catheter 90 having an expander 93 on the distal end is transported to a treatment site with the expander 93 in a contracted state. The treatment site is at or near the incompetent venous valve 24. The catheter 90 includes a lumen 91 having an opening 92 at or near the base of the expander 93. Referring to FIG. 13B, at the treatment site the expander 93 is expanded to at least the interior dimension of the vessel 31. The helical winding 94 is formed of a shape-memory material and is passed through the catheter lumen 91 in a substantially straight position, as shown in FIG. 13C. The helical winding 94 is pushed through the opening 92, which opening 92 is configured such that the winding 94 is directed toward the wall 44 of the vessel 31. The winding 94 penetrates and is pushed through the wall 44. The shape-memory effect causes the winding 94 to revert to a helix as the winding is pushed from the catheter lumen 91, and rides along the outside of the vessel 31. Once the helical winding 94 has completely exited the catheter lumen 91 and is situated about the exterior of the vessel 31, the expander 93 is contracted and the catheter 90 is withdrawn from the vessel. The helical winding 94 is configured so that when the shape-memory effect causes the winding to revert to a helix, the helical winding 94 pulls the wall 44 of the vessel 31 inwardly, causing the cusps 38 to pull together so that the valve can function competently. The winding 94 can be held in place by friction.
  • Referring to FIGS. 14A-14C, the closure device 100 can be an angular hinge-form with at least two linear legs 102. The closure device 100 can be transported in a compressed condition to a deployment site in the blood vessel by a delivery catheter 103 having a housing 105 for containing the closure device 100 in the compressed condition until the deployment site is reached. The device 100 can be pushed out of the housing 105 by the distal end of the catheter, which can be temporarily connected to the device 100, for example, by a threaded connection. Referring particularly to FIG. 14B, the device 100 will naturally expand upon being released from the confines of the housing 105. An expansion device 106, such as an inflatable balloon, on the distal end of the catheter 103 can be inflated to further expand the closure device 100 by spreading the legs 102 until the anchoring elements 104 penetrate the wall 44 of the blood vessel 41. The device 100 is then pulled in the direction of the catheter by the distal end of the catheter, which is still connected to the device 100. This movement causes the anchoring elements 104 to fully penetrate the wall of the blood vessel, and secure the device 100 to the vessel. The catheter is disconnected from the device 100 and removed from the vessel. The device 100 attempts to contract to a smaller condition, thus causing the cross section of the blood vessel to contract.
  • Referring to FIGS. 15A-15C, the expander can be a mechanical expander 135 including at least two coiled springs 128, 129 and having a two-part axial member including an outer tube 133 and an inner rod 134. The inner rod 134 is affixed to a first coil 129 and can rotate independently of the outer tube 133, which is affixed to a second coil 128. The mechanical expander 135 is used in conjunction with a closure device 125 configured to mount about the coils 128, 129. Each coil 128, 129 has an end 130, 131 configured to fit within a groove 127 formed on either end of the closure device 125. In this manner, the coils 128, 129 and closure device 125 are held together while the expansion device is transported to a treatment site. At the treatment site, the mechanical expander 135 is expanded to expand the closure device 125, thereby causing the anchoring portions 126 of the closure device 125 to penetrate a vessel wall, in a similar manner as described above.
  • The mechanical expander 135 expands by rotating the inner rod 134 to expand the first coil 129 and rotating the outer tube 133 to expand the second coil 128. The coils 128, 129 expand radially in opposite directions, exerting a radial force on the closure device 125, causing the anchoring portions 126 to penetrate a vessel wall. Once the closure device 125 is secured to the vessel wall, the mechanical expander 135 can be disengaged from the closure device 125 by sliding the mechanical expander 135 axially away from the closure device 125. The mechanical expander 135 is contracted by rotating the inner rod and outer tube in the opposite directions used for expansion, and is withdrawn from the vessel. Optionally, a retractable sheath can enclose the mechanical expander 135 and closure device 125 while positioning the assembly at the treatment site, which sheath is then retracted.
  • Referring to FIGS. 16A-16B, the expander can be a leveraging device 112 having at least two flexible legs 114, an axial member 115 and a splayed cuff 116. A closure device 117 can be mounted onto the exterior of the legs 114. At a deployment site, the axial member 115 can be pulled causing the legs 114 to press against the cuff 116. The force of the flexible legs 114 against the splayed cuff 116 causes the flexible legs 114 to expand outwardly and the splayed cuff 116 to fan out. The expansion of the circumference around the flexible legs 114 causes the closure device 117 to expand and anchor to the wall of the blood vessel 31, as described above. Once the closure device 117 is secured to the wall, the axial member 115 is pushed to release the pressure on the flexible legs 114, causing them to revert back to the original compressed condition. Similarly, with the force on the splayed cuff 116 removed, the cuff 116 recovers to the original state. The expansion device can then be retracted from the vessel.
  • Other embodiments are within the scope of the following claims. For example, a closure device may be used to treat vascular vessels at locations without a valve to constrict the vessel at a desired location and other body lumens outside the vascular system.

Claims (20)

1. An implantable medical closure device, comprising:
a flexible strand defining a continuous arcuate form having a first half with a first anchoring end and a second half with a second anchoring end, the first half and the second half being opposed relative a center line bisecting the flexible strand, where in a first state the flexible strand adjacent the first anchoring end and the second anchoring end provide for a tangential line that is parallel with the center line, and in a second state the flexible strand adjacent the first anchoring end and the second anchoring end provide for lines that are no longer parallel with the center line.
2. The device of claim 1, where the flexible strand is formed of a material that can provide a force to move the first anchoring end and the second anchoring end toward the first state.
3. The device of claim 2, where the material is a metal.
4. The device of claim 3, where the metal is nitinol.
5. The device of claim 1, where the strand is a filament-form.
6. The device of claim 1, where the first anchoring end and the second anchoring end include a barb.
7. The device of claim 1, where the flexible strand is a flexible polymer.
8. The device of claim 1, where the flexible strand defines at least one loop for the continuous arcuate form.
9. An implantable medical closure device, comprising:
a flexible member having a first half and a second half that extend from a center line in a continuous arcuate form, and having a first anchoring end and a second anchoring end opposed to the first anchoring end across the center line, where in a first state the flexible strand adjacent the first anchoring end and the second anchoring end provide for a tangential line that is parallel with the center line, and in a second state the flexible strand adjacent the first anchoring end and the second anchoring end provide for lines that are no longer parallel with the center line.
10. The device of claim 9, where the flexible strand is formed of a material that can provide a force to move the first anchoring end and the second anchoring end toward the first state.
11. The device of claim 10, where the material is nitinol.
12. The device of claim 9, where the first anchoring end and the second anchoring end include a barb.
13. The device of claim 9, where the flexible strand defines at least one loop for the continuous arcuate form.
14. A catheter system, comprising:
a catheter for delivery into a lumen, the catheter including an expander that can be operated between a small cross-section and a large cross-section; and
a closure device positioned about the expander, the closure device comprising a flexible strand defining a continuous arcuate form having a first half and a second half that extend from a center line, the first half having a first anchoring end and the second half having a second anchoring end, where when the closure device is positioned on the expander in the small cross-section the flexible strand adjacent the first anchoring end and the second anchoring end provide for a tangential line that is parallel with the center line, and when the closure device is positioned on the expanded in the large cross-section, relative the small cross-section, the flexible strand adjacent the first anchoring end and the second anchoring end provide for lines that are no longer parallel with the center line.
15. The catheter system of claim 14, where the expander comprises an inflatable balloon.
16. The catheter system of claim 14, where the expander comprises a mechanical expander.
17. The catheter system of claim 14, where the expander comprises a leveraging device.
18. The catheter system of claim 17, where the leveraging device comprises:
a two-part axial member including a first outer part and a second inner part;
a splayed cuff connected to the distal end of the first outer part of the two-part axial member; and
at least two flexible legs connected to the distal end of the second inner part of the two-part axial member and flared outwardly to contact the distal end of the splayed cuff.
19. The catheter system of claim 17, where the closure device is positioned about the flexible legs;
the second inner part of the two-part axial member is moveable in a first direction such that the flexible legs are pressed against the splayed cuff causing the flexible legs and the splayed cuff to expand radially; and
expansion of the flexible legs expands the closure device from the first small cross-section condition to the larger cross-section condition.
20. The catheter system of claim 19, where the second inner part of the two-part axial member is moveable in a second direction such that the flexible legs move away from the splayed cuff causing the flexible legs and the splayed cuff to retract.
US11/296,590 2002-04-03 2005-12-07 Body lumen closure Abandoned US20060085066A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/296,590 US20060085066A1 (en) 2002-04-03 2005-12-07 Body lumen closure

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/115,552 US7007698B2 (en) 2002-04-03 2002-04-03 Body lumen closure
US11/296,590 US20060085066A1 (en) 2002-04-03 2005-12-07 Body lumen closure

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/115,552 Continuation US7007698B2 (en) 2002-04-03 2002-04-03 Body lumen closure

Publications (1)

Publication Number Publication Date
US20060085066A1 true US20060085066A1 (en) 2006-04-20

Family

ID=28673796

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/115,552 Expired - Fee Related US7007698B2 (en) 2002-04-03 2002-04-03 Body lumen closure
US11/296,590 Abandoned US20060085066A1 (en) 2002-04-03 2005-12-07 Body lumen closure

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/115,552 Expired - Fee Related US7007698B2 (en) 2002-04-03 2002-04-03 Body lumen closure

Country Status (6)

Country Link
US (2) US7007698B2 (en)
EP (1) EP1489997A1 (en)
JP (1) JP4388821B2 (en)
AU (1) AU2003226217A1 (en)
CA (1) CA2480876A1 (en)
WO (1) WO2003084442A1 (en)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
KR101050626B1 (en) * 2002-08-29 2011-07-19 미트랄 솔루션스, 인크. Implantation device for controlling the inner circumference of the anatomical orifice or lumen
US7223266B2 (en) 2003-02-04 2007-05-29 Cardiodex Ltd. Methods and apparatus for hemostasis following arterial catheterization
US7056286B2 (en) * 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
EP1547526A1 (en) * 2003-12-23 2005-06-29 UMC Utrecht Holding B.V. Operation element, operation set and method for use thereof
JP5068662B2 (en) 2004-11-22 2012-11-07 カーディオデックス リミテッド Heat treatment technology for varicose veins
US7331991B2 (en) * 2005-02-25 2008-02-19 California Institute Of Technology Implantable small percutaneous valve and methods of delivery
US8864823B2 (en) * 2005-03-25 2014-10-21 StJude Medical, Cardiology Division, Inc. Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen
EP2626039B1 (en) * 2005-03-25 2015-10-14 St. Jude Medical, Cardiology Division, Inc. Apparatus for controlling the internal circumference of an anatomic orifice or lumen
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8502681B2 (en) 2005-06-20 2013-08-06 Biovigil, Llc Hand cleanliness
US7616122B2 (en) * 2005-06-20 2009-11-10 Biovigil, Llc Hand cleanliness
US7286057B2 (en) * 2005-06-20 2007-10-23 Biovigil Llc Hand cleanliness
US7936275B2 (en) * 2005-06-20 2011-05-03 Biovigil, Llc Hand cleanliness
US20070112423A1 (en) * 2005-11-16 2007-05-17 Chu Jack F Devices and methods for treatment of venous valve insufficiency
US7780724B2 (en) * 2006-02-24 2010-08-24 California Institute Of Technology Monolithic in situ forming valve system
US20080275550A1 (en) * 2006-02-24 2008-11-06 Arash Kheradvar Implantable small percutaneous valve and methods of delivery
US7955380B2 (en) * 2006-03-17 2011-06-07 Medtronic Vascular, Inc. Prosthesis fixation apparatus and methods
JP5148598B2 (en) 2006-05-03 2013-02-20 ラプトール リッジ, エルエルシー Tissue closure system and method
US20080031838A1 (en) * 2006-08-03 2008-02-07 Bolling Steven F Tracing hand cleaner
US9138208B2 (en) * 2006-08-09 2015-09-22 Coherex Medical, Inc. Devices for reducing the size of an internal tissue opening
US8529597B2 (en) 2006-08-09 2013-09-10 Coherex Medical, Inc. Devices for reducing the size of an internal tissue opening
US20080039743A1 (en) 2006-08-09 2008-02-14 Coherex Medical, Inc. Methods for determining characteristics of an internal tissue opening
US8784439B1 (en) * 2006-11-28 2014-07-22 Stephen V. Ward Percutaneous medical procedures and devices for closing vessels using mechanical closures
EP2111189B1 (en) * 2007-01-03 2017-04-05 St. Jude Medical, Cardiology Division, Inc. Implantable devices for controlling the size and shape of an anatomical structure or lumen
US8133270B2 (en) * 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
US9192471B2 (en) * 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US20100249920A1 (en) * 2007-01-08 2010-09-30 Millipede Llc Reconfiguring heart features
US20100121433A1 (en) * 2007-01-08 2010-05-13 Millipede Llc, A Corporation Of Michigan Reconfiguring heart features
US20080215072A1 (en) * 2007-02-15 2008-09-04 Graham Kelly Methods and apparatus for utilization of barbed sutures in human tissue including a method for eliminating or improving blood flow in veins
US8366706B2 (en) 2007-08-15 2013-02-05 Cardiodex, Ltd. Systems and methods for puncture closure
US8834551B2 (en) 2007-08-31 2014-09-16 Rex Medical, L.P. Vascular device with valve for approximating vessel wall
US20090149847A1 (en) * 2007-10-05 2009-06-11 Cardiodex Ltd. Systems and methods for puncture closure
US7896911B2 (en) 2007-12-12 2011-03-01 Innovasc Llc Device and method for tacking plaque to blood vessel wall
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
US8128677B2 (en) 2007-12-12 2012-03-06 Intact Vascular LLC Device and method for tacking plaque to a blood vessel wall
US9603730B2 (en) 2007-12-12 2017-03-28 Intact Vascular, Inc. Endoluminal device and method
US9375327B2 (en) 2007-12-12 2016-06-28 Intact Vascular, Inc. Endovascular implant
US20110230954A1 (en) * 2009-06-11 2011-09-22 Peter Schneider Stent device having focal elevating elements for minimal surface area contact with lumen walls
US10022250B2 (en) 2007-12-12 2018-07-17 Intact Vascular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US11219750B2 (en) 2008-03-21 2022-01-11 Cagent Vascular, Inc. System and method for plaque serration
EP2254641B1 (en) 2008-03-21 2016-09-21 Cagent Vascular, LLC Device for pre-angioplasty serration and dilatation
US9480826B2 (en) * 2008-03-21 2016-11-01 Cagent Vascular, Llc Intravascular device
US20090248142A1 (en) 2008-03-25 2009-10-01 Medtronic Vascular, Inc. Methods, Devices and Systems for Treating Venous Insufficiency
WO2009121001A1 (en) * 2008-03-28 2009-10-01 Coherex Medical, Inc. Delivery systems for a medical device and related methods
US10016196B2 (en) * 2008-09-11 2018-07-10 Covidien Lp Tapered looped suture
US20100204729A1 (en) * 2008-09-11 2010-08-12 Ahmad Robert Hadba Tapered Looped Suture
AU2010206732A1 (en) * 2009-01-22 2011-08-25 St. Jude Medical, Cardiology Division, Inc. Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring
WO2010106543A2 (en) * 2009-03-20 2010-09-23 Proarc Medical Ltd. Methods and devices for urethral treatment
US8292948B2 (en) * 2010-02-17 2012-10-23 Medtronic Vascular, Inc. Apparatus and methods for creating a venous valve from autologous tissue
US9504572B2 (en) * 2010-02-17 2016-11-29 Medtronic Vascular, Inc. Apparatus and methods for creating a venous valve from autologous tissue
US8496671B1 (en) * 2010-06-16 2013-07-30 Cardica, Inc. Mitral valve treatment
US20120053680A1 (en) 2010-08-24 2012-03-01 Bolling Steven F Reconfiguring Heart Features
WO2012123950A2 (en) * 2011-03-17 2012-09-20 Proarc Medical Ltd. Methods and devices for urethral
US10390977B2 (en) 2011-06-03 2019-08-27 Intact Vascular, Inc. Endovascular implant
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
AU2013212056B2 (en) 2012-01-25 2016-07-21 Intact Vascular, Inc. Endoluminal device and method
US9168122B2 (en) 2012-04-26 2015-10-27 Rex Medical, L.P. Vascular device and method for valve leaflet apposition
US10849755B2 (en) 2012-09-14 2020-12-01 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US10543088B2 (en) 2012-09-14 2020-01-28 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
EP2967819B1 (en) 2013-03-14 2021-04-28 Proarc Medical Ltd. Devices for urethral treatment
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US10485545B2 (en) 2013-11-19 2019-11-26 Datascope Corp. Fastener applicator with interlock
US9668861B2 (en) 2014-03-15 2017-06-06 Rex Medical, L.P. Vascular device for treating venous valve insufficiency
WO2015187872A1 (en) 2014-06-04 2015-12-10 Cagent Vascular, Llc Cage for medical balloon
US9180005B1 (en) 2014-07-17 2015-11-10 Millipede, Inc. Adjustable endolumenal mitral valve ring
CA2969535A1 (en) 2014-11-03 2016-05-12 Cagent Vascular, Llc Serration balloon
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
EP3256077A4 (en) 2015-02-13 2019-02-27 Millipede, Inc. Valve replacement using rotational anchors
JP6766078B2 (en) 2015-06-01 2020-10-07 エドワーズ ライフサイエンシーズ コーポレイションEdwards Lifesciences Corporation Heart valve repair device configured for percutaneous delivery
US20170020671A1 (en) * 2015-07-22 2017-01-26 Boston Scientific Scimed Inc. Actuated extra-venous valve
US10166374B2 (en) 2015-09-17 2019-01-01 Cagent Vascular, Llc Wedge dissectors for a medical balloon
US10335275B2 (en) 2015-09-29 2019-07-02 Millipede, Inc. Methods for delivery of heart valve devices using intravascular ultrasound imaging
ES2554296B1 (en) * 2015-10-02 2017-01-18 Jose Ignacio ARAMENDI GALLARDO REABSORBABLE SUBAORTIC RING
EP3377000B1 (en) 2015-11-17 2023-02-01 Boston Scientific Scimed, Inc. Implantable device and delivery system for reshaping a heart valve annulus
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
US20200146854A1 (en) 2016-05-16 2020-05-14 Elixir Medical Corporation Methods and devices for heart valve repair
AU2017361422B2 (en) 2016-11-16 2023-07-06 Cagent Vascular, Inc. Systems and methods of depositing drug into tissue through serrations
IT201700001625A1 (en) * 2017-01-10 2018-07-10 Tarabini Carlo Castellani CORRECTIVE PROSTHESIS FOR PROLASSED BIOLOGICAL VASES
WO2018148584A1 (en) 2017-02-10 2018-08-16 Millipede, Inc. Implantable device and delivery system for reshaping a heart valve annulus
US11069220B2 (en) 2017-07-10 2021-07-20 Biovigil Hygiene Technologies, Llc Hand cleanliness monitoring
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
US11109867B2 (en) 2018-03-16 2021-09-07 Boston Scientific Scimed, Inc. Devices and methods for vein closure
WO2019191271A1 (en) 2018-03-28 2019-10-03 Datascope Corp. Device for atrial appendage exclusion
CN112739406A (en) 2018-07-25 2021-04-30 开金血管有限公司 Medical balloon catheter with enhanced pushability

Citations (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3716058A (en) * 1970-07-17 1973-02-13 Atlanta Res Inst Barbed suture
US4904254A (en) * 1986-07-17 1990-02-27 Vaso Products Australia Pty. Limited Correction of incompetent venous valves
US5002563A (en) * 1990-02-22 1991-03-26 Raychem Corporation Sutures utilizing shape memory alloys
US5601572A (en) * 1989-08-16 1997-02-11 Raychem Corporation Device or apparatus for manipulating matter having a elastic ring clip
US20020013571A1 (en) * 1999-04-09 2002-01-31 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US20020026216A1 (en) * 1999-10-13 2002-02-28 Grimes Randall Y. Devices and methods for percutaneous mitral valve repair
US20030050694A1 (en) * 2001-09-13 2003-03-13 Jibin Yang Methods and apparatuses for deploying minimally-invasive heart valves
US20040002719A1 (en) * 1997-06-27 2004-01-01 Oz Mehmet C. Method and apparatus for circulatory valve repair
US6673109B2 (en) * 1993-11-01 2004-01-06 3F Therapeutics, Inc. Replacement atrioventricular heart valve
US20040003819A1 (en) * 1999-04-09 2004-01-08 Evalve, Inc. Methods and apparatus for cardiac valve repair
US6676702B2 (en) * 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US20040010305A1 (en) * 2001-12-05 2004-01-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040015230A1 (en) * 1996-12-18 2004-01-22 Moll Franciscus Laurens Methods for regulating the flow of blood through the blood system
US20040015232A1 (en) * 2002-07-16 2004-01-22 Medtronic, Inc. Suturing rings for implantable heart valve prosthesis
US20040015233A1 (en) * 2000-10-09 2004-01-22 Josef Jansen Cardiac valve prosthesis, especially mitral cardiac valve and method for producing the same
US6682558B2 (en) * 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US6682559B2 (en) * 2000-01-27 2004-01-27 3F Therapeutics, Inc. Prosthetic heart valve
US20040019374A1 (en) * 2002-05-10 2004-01-29 Hikmat Hojeibane Frame based unidirectional flow prosthetic implant
US20040019378A1 (en) * 2001-04-24 2004-01-29 Hlavka Edwin J. Method and apparatus for performing catheter-based annuloplasty
US20040019377A1 (en) * 2002-01-14 2004-01-29 Taylor Daniel C. Method and apparatus for reducing mitral regurgitation
US6685739B2 (en) * 1999-10-21 2004-02-03 Scimed Life Systems, Inc. Implantable prosthetic valve
US20040024452A1 (en) * 2002-08-02 2004-02-05 Kruse Steven D. Valved prostheses with preformed tissue leaflets
US20040024451A1 (en) * 2002-01-02 2004-02-05 Medtronic, Inc. Prosthetic heart valve system
US20040024447A1 (en) * 2000-04-27 2004-02-05 Axel Haverich Individual venous valve prosthesis
US20040030405A1 (en) * 1994-07-29 2004-02-12 Sophie Carpentier Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US20040030321A1 (en) * 2000-07-11 2004-02-12 Fangrow Thomas F. Medical valve with positive flow characteristics
US20040030381A1 (en) * 2002-07-16 2004-02-12 Shu Mark C.S. Heart valve prosthesis
US6692512B2 (en) * 1998-10-13 2004-02-17 Edwards Lifesciences Corporation Percutaneous filtration catheter for valve repair surgery and methods of use
US20040034380A1 (en) * 2001-06-29 2004-02-19 Woolfson Steven B. Method and apparatus for resecting and replacing an aortic valve
US20040034411A1 (en) * 2002-08-16 2004-02-19 Quijano Rodolfo C. Percutaneously delivered heart valve and delivery means thereof
US6695866B1 (en) * 1998-07-15 2004-02-24 St. Jude Medical, Inc. Mitral and tricuspid valve repair
US6695878B2 (en) * 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US20040039436A1 (en) * 2001-10-11 2004-02-26 Benjamin Spenser Implantable prosthetic valve
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US20040044350A1 (en) * 1999-04-09 2004-03-04 Evalve, Inc. Steerable access sheath and methods of use
US6837902B2 (en) * 1997-04-03 2005-01-04 Edwards Lifesciences Corporation Methods of making bioprosthetic heart valves with strain matched leaflets
US20050004667A1 (en) * 2003-06-05 2005-01-06 Cardiac Dimensions, Inc. A Delaware Corporation Device, system and method to affect the mitral valve annulus of a heart
US6840246B2 (en) * 2000-06-20 2005-01-11 University Of Maryland, Baltimore Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart
US20050010285A1 (en) * 1999-01-27 2005-01-13 Lambrecht Gregory H. Cardiac valve procedure methods and devices
US20050010287A1 (en) * 2000-09-20 2005-01-13 Ample Medical, Inc. Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet
US20050015112A1 (en) * 2000-01-27 2005-01-20 Cohn William E. Cardiac valve procedure methods and devices
US6846324B2 (en) * 1999-01-26 2005-01-25 Edwards Lifesciences Corporation Combination anatomical orifice sizer and heart valve
US6846325B2 (en) * 2000-09-07 2005-01-25 Viacor, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20050021136A1 (en) * 2002-03-21 2005-01-27 Hua Xie Method for suturelessly attaching a biomaterial to an implantable bioprosthesis frame
US20050027353A1 (en) * 2001-05-14 2005-02-03 Alferness Clifton A. Mitral valve therapy device, system and method
US20050027261A1 (en) * 2003-07-30 2005-02-03 Karla Weaver Pressure actuated valve with improved slit configuration
US20050027348A1 (en) * 2003-07-31 2005-02-03 Case Brian C. Prosthetic valve devices and methods of making such devices
US20050033398A1 (en) * 2001-07-31 2005-02-10 Jacques Seguin Assembly for setting a valve prosthesis in a corporeal duct
US20050038506A1 (en) * 2002-11-15 2005-02-17 Webler William E. Apparatuses and methods for heart valve repair
US6858039B2 (en) * 2002-07-08 2005-02-22 Edwards Lifesciences Corporation Mitral valve annuloplasty ring having a posterior bow
US20050043790A1 (en) * 2001-07-04 2005-02-24 Jacques Seguin Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US20060000715A1 (en) * 2000-01-25 2006-01-05 Whitcher Forrest D Manufacturing medical devices by vapor deposition
US20060004442A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Paravalvular leak detection, sealing, and prevention
US20060004439A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Device and method for assisting in the implantation of a prosthetic valve
US20060009841A1 (en) * 2003-05-05 2006-01-12 Rex Medical Percutaneous aortic valve
US20060009804A1 (en) * 2004-07-12 2006-01-12 Pederson Brian D Anti-coagulation and demineralization system for conductive medical devices
US20060009842A1 (en) * 1997-03-27 2006-01-12 Huynh Van L Contoured heart valve suture rings
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060015136A1 (en) * 2002-09-19 2006-01-19 Memory Metal Holland Bv Vascular filter with improved strength and flexibility
US20060015179A1 (en) * 2004-07-19 2006-01-19 Neil Bulman-Fleming Aortic annuloplasty ring
US20060013855A1 (en) * 2004-04-05 2006-01-19 Medivas, Llc Bioactive stents for type II diabetics and methods for use thereof
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US20060013805A1 (en) * 1998-11-24 2006-01-19 Regents Of The University Of Minnesota Transgenic circulating endothelial cells
US6989028B2 (en) * 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US6989027B2 (en) * 2003-04-30 2006-01-24 Medtronic Vascular Inc. Percutaneously delivered temporary valve assembly
US20060020327A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Nonstented heart valves with formed in situ support
US20060020335A1 (en) * 2002-12-26 2006-01-26 Leonard Kowalsky System and method to effect the mitral valve annulus of a heart
US20060020336A1 (en) * 2001-10-23 2006-01-26 Liddicoat John R Automated annular plication for mitral valve repair
US20060020275A1 (en) * 1999-04-09 2006-01-26 Evalve, Inc. Locking mechanisms for fixation devices and methods of engaging tissue
US20060025784A1 (en) * 2003-09-04 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060025856A1 (en) * 2001-03-15 2006-02-02 Medtronic, Inc. Annuloplasty band and method
US20060025857A1 (en) * 2004-04-23 2006-02-02 Bjarne Bergheim Implantable prosthetic valve
US20060025750A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060030866A1 (en) * 2002-03-26 2006-02-09 Stefan Schreck Sequential heart valve leaflet repair device and method of use
US20060030882A1 (en) * 2002-03-06 2006-02-09 Adams John M Transvenous staples, assembly and method for mitral valve repair
US20060030885A1 (en) * 2002-10-15 2006-02-09 Hyde Gregory M Apparatuses and methods for heart valve repair
US20060030747A1 (en) * 2004-07-09 2006-02-09 Kantrowitz Allen B Synchronization system between aortic valve and cardiac assist device
US6997950B2 (en) * 2003-01-16 2006-02-14 Chawla Surendra K Valve repair device
US20060036317A1 (en) * 2002-11-12 2006-02-16 Myocor, Inc. Decives and methods for heart valve treatment
US20060041305A1 (en) * 1996-06-20 2006-02-23 Karl-Lutz Lauterjung Prosthetic repair of body passages
US20060041306A1 (en) * 2002-01-09 2006-02-23 Myocor, Inc. Devices and methods for heart valve treatment
US7004176B2 (en) * 2003-10-17 2006-02-28 Edwards Lifesciences Ag Heart valve leaflet locator

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170990A (en) * 1977-01-28 1979-10-16 Fried. Krupp Gesellschaft Mit Beschrankter Haftung Method for implanting and subsequently removing mechanical connecting elements from living tissue
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4872874A (en) 1987-05-29 1989-10-10 Taheri Syde A Method and apparatus for transarterial aortic graft insertion and implantation
US5053047A (en) * 1989-05-16 1991-10-01 Inbae Yoon Suture devices particularly useful in endoscopic surgery and methods of suturing
US5290300A (en) 1989-07-31 1994-03-01 Baxter International Inc. Flexible suture guide and holder
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
IL106738A (en) 1993-08-19 1998-02-08 Mind E M S G Ltd Device for external correction of deficient valves in venous junctions
US5582616A (en) * 1994-08-05 1996-12-10 Origin Medsystems, Inc. Surgical helical fastener with applicator
US5549666A (en) 1994-09-02 1996-08-27 Baxter International Inc. Natural tissue valve prostheses having variably complaint leaflets
US5609598A (en) 1994-12-30 1997-03-11 Vnus Medical Technologies, Inc. Method and apparatus for minimally invasive treatment of chronic venous insufficiency
DE69635479T2 (en) 1995-06-07 2006-06-08 St. Jude Medical, Inc., St. Paul PROSTHETIC HEARTLAP WITH ENLARGED LUMEN
US6764509B2 (en) 1996-09-06 2004-07-20 Carbomedics Inc. Prosthetic heart valve with surface modification
US5957949A (en) 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6071292A (en) 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US6059800A (en) 1997-09-10 2000-05-09 Applied Medical Resources Corporation Suturing apparatus and method
FR2768324B1 (en) 1997-09-12 1999-12-10 Jacques Seguin SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER
US5989268A (en) * 1997-10-28 1999-11-23 Boston Scientific Corporation Endoscopic hemostatic clipping device
US6074418A (en) 1998-04-20 2000-06-13 St. Jude Medical, Inc. Driver tool for heart valve prosthesis fasteners
US6250308B1 (en) 1998-06-16 2001-06-26 Cardiac Concepts, Inc. Mitral valve annuloplasty ring and method of implanting
US6736845B2 (en) 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
US6364905B1 (en) 1999-01-27 2002-04-02 Sulzer Carbomedics Inc. Tri-composite, full root, stentless valve
US6179767B1 (en) * 1999-02-01 2001-01-30 International Business Machines Corporation Focussing of therapeutic radiation on internal structures of living bodies
US6666886B1 (en) 1999-02-16 2003-12-23 Regents Of The University Of Minnesota Tissue equivalent approach to a tissue-engineered cardiovascular valve
US7563267B2 (en) * 1999-04-09 2009-07-21 Evalve, Inc. Fixation device and methods for engaging tissue
US6666885B2 (en) 1999-04-16 2003-12-23 Carbomedics Inc. Heart valve leaflet
JP2002541974A (en) * 1999-04-28 2002-12-10 セント・ジュード・メディカル・インコーポレーテッド Heart substitute valve
US6790229B1 (en) 1999-05-25 2004-09-14 Eric Berreklouw Fixing device, in particular for fixing to vascular wall tissue
US6241763B1 (en) 1999-06-08 2001-06-05 William J. Drasler In situ venous valve device and method of formation
DE19945587A1 (en) 1999-09-23 2001-05-10 Co Don Ag Procedure for inserting implants into human organs
AU1068800A (en) 1999-11-10 2001-06-06 Impsa International Incorporated Prosthetic heart valve
FR2800984B1 (en) 1999-11-17 2001-12-14 Jacques Seguin DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY
US6709457B1 (en) 1999-11-24 2004-03-23 St. Jude Medical, Inc. Attachment of suture cuff to prosthetic heart valve
US6769434B2 (en) 2000-06-30 2004-08-03 Viacor, Inc. Method and apparatus for performing a procedure on a cardiac valve
US6402781B1 (en) 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US6821297B2 (en) 2000-02-02 2004-11-23 Robert V. Snyders Artificial heart valve, implantation instrument and method therefor
US6797002B2 (en) 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US7083628B2 (en) * 2002-09-03 2006-08-01 Edwards Lifesciences Corporation Single catheter mitral valve repair device and method for use
US6805711B2 (en) 2000-06-02 2004-10-19 3F Therapeutics, Inc. Expandable medical implant and percutaneous delivery
US6419696B1 (en) 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US6693512B1 (en) * 2000-07-17 2004-02-17 Armstrong World Industries, Inc. Device location and identification system
SE0002878D0 (en) 2000-08-11 2000-08-11 Kimblad Ola Device and method of treatment of atrioventricular regurgitation
US6716224B2 (en) * 2000-08-28 2004-04-06 Linvatec Corporation Intracorporeal knot tier
DE10046550A1 (en) 2000-09-19 2002-03-28 Adiam Life Science Ag Prosthetic mitral heart valve consists of support housing with base ring and two stanchions
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
DE10049865B8 (en) 2000-10-09 2008-10-30 Universitätsklinikum Freiburg Device for removing an aortic valve on the human heart by means of a minimally invasive surgical procedure
US6602286B1 (en) * 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US6730122B1 (en) 2000-11-28 2004-05-04 St. Jude Medical, Inc. Prosthetic heart valve with increased lumen
US6716244B2 (en) 2000-12-20 2004-04-06 Carbomedics, Inc. Sewing cuff assembly for heart valves
US6669725B2 (en) 2000-12-28 2003-12-30 Centerpulse Biologics Inc. Annuloplasty ring for regeneration of diseased or damaged heart valve annulus
US6810882B2 (en) 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
CA2437824C (en) 2001-02-05 2008-09-23 Viacor, Inc. Apparatus and method for reducing mitral regurgitation
US6786924B2 (en) 2001-03-15 2004-09-07 Medtronic, Inc. Annuloplasty band and method
US6916338B2 (en) * 2001-03-16 2005-07-12 Mayo Foundation For Medical Education And Research Synthetic leaflets for heart valve repair or replacement
DE10121210B4 (en) 2001-04-30 2005-11-17 Universitätsklinikum Freiburg Anchoring element for the intraluminal anchoring of a heart valve replacement and method for its production
ITMI20011012A1 (en) 2001-05-17 2002-11-17 Ottavio Alfieri ANNULAR PROSTHESIS FOR MITRAL VALVE
US7087088B2 (en) * 2001-05-24 2006-08-08 Torax Medical, Inc. Methods and apparatus for regulating the flow of matter through body tubing
US6558400B2 (en) * 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US6726716B2 (en) 2001-08-24 2004-04-27 Edwards Lifesciences Corporation Self-molding annuloplasty ring
US6749630B2 (en) 2001-08-28 2004-06-15 Edwards Lifesciences Corporation Tricuspid ring and template
US6723122B2 (en) 2001-08-30 2004-04-20 Edwards Lifesciences Corporation Container and method for storing and delivering minimally-invasive heart valves
US6726715B2 (en) 2001-10-23 2004-04-27 Childrens Medical Center Corporation Fiber-reinforced heart valve prosthesis
US20040044403A1 (en) * 2001-10-30 2004-03-04 Joyce Bischoff Tissue-engineered vascular structures
US7311729B2 (en) 2002-01-30 2007-12-25 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US6824562B2 (en) 2002-05-08 2004-11-30 Cardiac Dimensions, Inc. Body lumen device anchor, device and assembly
US6805710B2 (en) 2001-11-13 2004-10-19 Edwards Lifesciences Corporation Mitral valve annuloplasty ring for molding left ventricle geometry
US6719784B2 (en) 2001-11-21 2004-04-13 Scimed Life Systems, Inc. Counter rotational layering of ePTFE to improve mechanical properties of a prosthesis
US6755857B2 (en) 2001-12-12 2004-06-29 Sulzer Carbomedics Inc. Polymer heart valve with perforated stent and sewing cuff
US7125420B2 (en) * 2002-02-05 2006-10-24 Viacor, Inc. Method and apparatus for improving mitral valve function
US6716241B2 (en) 2002-03-05 2004-04-06 John G. Wilder Venous valve and graft combination
US6797001B2 (en) 2002-03-11 2004-09-28 Cardiac Dimensions, Inc. Device, assembly and method for mitral valve repair
US6719786B2 (en) 2002-03-18 2004-04-13 Medtronic, Inc. Flexible annuloplasty prosthesis and holder
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US6761735B2 (en) 2002-04-25 2004-07-13 Medtronic, Inc. Heart valve fixation process and apparatus
US20030229394A1 (en) 2002-06-06 2003-12-11 Ogle Matthew F. Processed tissue for medical device formation
AU2003247526A1 (en) * 2002-06-12 2003-12-31 Mitral Interventions, Inc. Method and apparatus for tissue connection
US6761734B2 (en) 2002-07-22 2004-07-13 William S. Suhr Segmented balloon catheter for stenting bifurcation lesions
US8172856B2 (en) * 2002-08-02 2012-05-08 Cedars-Sinai Medical Center Methods and apparatus for atrioventricular valve repair
US6695886B1 (en) 2002-08-22 2004-02-24 Axcelis Technologies, Inc. Optical path improvement, focus length change compensation, and stray light reduction for temperature measurement system of RTP tool
US6875231B2 (en) * 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
US20040059412A1 (en) * 2002-09-25 2004-03-25 Lytle Thomas William Heart valve holder
US20040060161A1 (en) * 2002-09-27 2004-04-01 David Leal Methods of forming a heart valve stent
GB0225075D0 (en) * 2002-10-29 2002-12-04 Smiths Group Plc Valves
US20040082910A1 (en) * 2002-10-29 2004-04-29 Constantz Brent R. Devices and methods for treating aortic valve stenosis
US6830585B1 (en) 2003-01-14 2004-12-14 3F Therapeutics, Inc. Percutaneously deliverable heart valve and methods of implantation

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3716058A (en) * 1970-07-17 1973-02-13 Atlanta Res Inst Barbed suture
US4904254A (en) * 1986-07-17 1990-02-27 Vaso Products Australia Pty. Limited Correction of incompetent venous valves
US5601572A (en) * 1989-08-16 1997-02-11 Raychem Corporation Device or apparatus for manipulating matter having a elastic ring clip
US5002563A (en) * 1990-02-22 1991-03-26 Raychem Corporation Sutures utilizing shape memory alloys
US6673109B2 (en) * 1993-11-01 2004-01-06 3F Therapeutics, Inc. Replacement atrioventricular heart valve
US20040030405A1 (en) * 1994-07-29 2004-02-12 Sophie Carpentier Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US20060041305A1 (en) * 1996-06-20 2006-02-23 Karl-Lutz Lauterjung Prosthetic repair of body passages
US20040015230A1 (en) * 1996-12-18 2004-01-22 Moll Franciscus Laurens Methods for regulating the flow of blood through the blood system
US20060009842A1 (en) * 1997-03-27 2006-01-12 Huynh Van L Contoured heart valve suture rings
US6837902B2 (en) * 1997-04-03 2005-01-04 Edwards Lifesciences Corporation Methods of making bioprosthetic heart valves with strain matched leaflets
US20040002719A1 (en) * 1997-06-27 2004-01-01 Oz Mehmet C. Method and apparatus for circulatory valve repair
US20050004583A1 (en) * 1997-06-27 2005-01-06 Oz Mehmet C. Method and apparatus for circulatory valve repair
US6695866B1 (en) * 1998-07-15 2004-02-24 St. Jude Medical, Inc. Mitral and tricuspid valve repair
US6692512B2 (en) * 1998-10-13 2004-02-17 Edwards Lifesciences Corporation Percutaneous filtration catheter for valve repair surgery and methods of use
US20060013805A1 (en) * 1998-11-24 2006-01-19 Regents Of The University Of Minnesota Transgenic circulating endothelial cells
US6846324B2 (en) * 1999-01-26 2005-01-25 Edwards Lifesciences Corporation Combination anatomical orifice sizer and heart valve
US20050010285A1 (en) * 1999-01-27 2005-01-13 Lambrecht Gregory H. Cardiac valve procedure methods and devices
US20040039442A1 (en) * 1999-04-09 2004-02-26 Evalve, Inc. Methods and apparatus for cardiac valve repair
US20060020275A1 (en) * 1999-04-09 2006-01-26 Evalve, Inc. Locking mechanisms for fixation devices and methods of engaging tissue
US20050033446A1 (en) * 1999-04-09 2005-02-10 Evalve, Inc. A California Corporation Methods and apparatus for cardiac valve repair
US20040044350A1 (en) * 1999-04-09 2004-03-04 Evalve, Inc. Steerable access sheath and methods of use
US20050021056A1 (en) * 1999-04-09 2005-01-27 Evalve, Inc. Leaflet structuring
US20040003819A1 (en) * 1999-04-09 2004-01-08 Evalve, Inc. Methods and apparatus for cardiac valve repair
US20020013571A1 (en) * 1999-04-09 2002-01-31 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US20040030382A1 (en) * 1999-04-09 2004-02-12 Evalve, Inc. Methods and apparatus for cardiac valve repair
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US6997951B2 (en) * 1999-06-30 2006-02-14 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US20020026216A1 (en) * 1999-10-13 2002-02-28 Grimes Randall Y. Devices and methods for percutaneous mitral valve repair
US6840957B2 (en) * 1999-10-21 2005-01-11 Scimed Life Systems, Inc. Implantable prosthetic valve
US6685739B2 (en) * 1999-10-21 2004-02-03 Scimed Life Systems, Inc. Implantable prosthetic valve
US20060000715A1 (en) * 2000-01-25 2006-01-05 Whitcher Forrest D Manufacturing medical devices by vapor deposition
US20050015112A1 (en) * 2000-01-27 2005-01-20 Cohn William E. Cardiac valve procedure methods and devices
US6682559B2 (en) * 2000-01-27 2004-01-27 3F Therapeutics, Inc. Prosthetic heart valve
US6989028B2 (en) * 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US20040024447A1 (en) * 2000-04-27 2004-02-05 Axel Haverich Individual venous valve prosthesis
US6840246B2 (en) * 2000-06-20 2005-01-11 University Of Maryland, Baltimore Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart
US6695878B2 (en) * 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US20040030321A1 (en) * 2000-07-11 2004-02-12 Fangrow Thomas F. Medical valve with positive flow characteristics
US6846325B2 (en) * 2000-09-07 2005-01-25 Viacor, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20050010287A1 (en) * 2000-09-20 2005-01-13 Ample Medical, Inc. Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet
US20040015233A1 (en) * 2000-10-09 2004-01-22 Josef Jansen Cardiac valve prosthesis, especially mitral cardiac valve and method for producing the same
US20060025856A1 (en) * 2001-03-15 2006-02-02 Medtronic, Inc. Annuloplasty band and method
US20040019378A1 (en) * 2001-04-24 2004-01-29 Hlavka Edwin J. Method and apparatus for performing catheter-based annuloplasty
US6682558B2 (en) * 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US20050027351A1 (en) * 2001-05-14 2005-02-03 Cardiac Dimensions, Inc. A Washington Corporation Mitral valve regurgitation treatment device and method
US20050027353A1 (en) * 2001-05-14 2005-02-03 Alferness Clifton A. Mitral valve therapy device, system and method
US20050033419A1 (en) * 2001-05-14 2005-02-10 Alferness Clifton A. Mitral valve therapy device, system and method
US6676702B2 (en) * 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US20050038507A1 (en) * 2001-05-14 2005-02-17 Alferness Clifton A. Mitral valve therapy device, system and method
US20040034380A1 (en) * 2001-06-29 2004-02-19 Woolfson Steven B. Method and apparatus for resecting and replacing an aortic valve
US20050043790A1 (en) * 2001-07-04 2005-02-24 Jacques Seguin Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body
US20050033398A1 (en) * 2001-07-31 2005-02-10 Jacques Seguin Assembly for setting a valve prosthesis in a corporeal duct
US20030050694A1 (en) * 2001-09-13 2003-03-13 Jibin Yang Methods and apparatuses for deploying minimally-invasive heart valves
US20040039436A1 (en) * 2001-10-11 2004-02-26 Benjamin Spenser Implantable prosthetic valve
US20060020336A1 (en) * 2001-10-23 2006-01-26 Liddicoat John R Automated annular plication for mitral valve repair
US20040010305A1 (en) * 2001-12-05 2004-01-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040024451A1 (en) * 2002-01-02 2004-02-05 Medtronic, Inc. Prosthetic heart valve system
US20060041306A1 (en) * 2002-01-09 2006-02-23 Myocor, Inc. Devices and methods for heart valve treatment
US20040019377A1 (en) * 2002-01-14 2004-01-29 Taylor Daniel C. Method and apparatus for reducing mitral regurgitation
US20060030882A1 (en) * 2002-03-06 2006-02-09 Adams John M Transvenous staples, assembly and method for mitral valve repair
US20050021136A1 (en) * 2002-03-21 2005-01-27 Hua Xie Method for suturelessly attaching a biomaterial to an implantable bioprosthesis frame
US20060030866A1 (en) * 2002-03-26 2006-02-09 Stefan Schreck Sequential heart valve leaflet repair device and method of use
US20040019374A1 (en) * 2002-05-10 2004-01-29 Hikmat Hojeibane Frame based unidirectional flow prosthetic implant
US20060025750A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060025787A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US6858039B2 (en) * 2002-07-08 2005-02-22 Edwards Lifesciences Corporation Mitral valve annuloplasty ring having a posterior bow
US20040030381A1 (en) * 2002-07-16 2004-02-12 Shu Mark C.S. Heart valve prosthesis
US20040015232A1 (en) * 2002-07-16 2004-01-22 Medtronic, Inc. Suturing rings for implantable heart valve prosthesis
US20040024452A1 (en) * 2002-08-02 2004-02-05 Kruse Steven D. Valved prostheses with preformed tissue leaflets
US20040034411A1 (en) * 2002-08-16 2004-02-19 Quijano Rodolfo C. Percutaneously delivered heart valve and delivery means thereof
US20060015136A1 (en) * 2002-09-19 2006-01-19 Memory Metal Holland Bv Vascular filter with improved strength and flexibility
US20060030885A1 (en) * 2002-10-15 2006-02-09 Hyde Gregory M Apparatuses and methods for heart valve repair
US20060036317A1 (en) * 2002-11-12 2006-02-16 Myocor, Inc. Decives and methods for heart valve treatment
US20050038506A1 (en) * 2002-11-15 2005-02-17 Webler William E. Apparatuses and methods for heart valve repair
US20060020335A1 (en) * 2002-12-26 2006-01-26 Leonard Kowalsky System and method to effect the mitral valve annulus of a heart
US6997950B2 (en) * 2003-01-16 2006-02-14 Chawla Surendra K Valve repair device
US6989027B2 (en) * 2003-04-30 2006-01-24 Medtronic Vascular Inc. Percutaneously delivered temporary valve assembly
US20060009841A1 (en) * 2003-05-05 2006-01-12 Rex Medical Percutaneous aortic valve
US20050004667A1 (en) * 2003-06-05 2005-01-06 Cardiac Dimensions, Inc. A Delaware Corporation Device, system and method to affect the mitral valve annulus of a heart
US20050027261A1 (en) * 2003-07-30 2005-02-03 Karla Weaver Pressure actuated valve with improved slit configuration
US20050027348A1 (en) * 2003-07-31 2005-02-03 Case Brian C. Prosthetic valve devices and methods of making such devices
US20060025784A1 (en) * 2003-09-04 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US7004176B2 (en) * 2003-10-17 2006-02-28 Edwards Lifesciences Ag Heart valve leaflet locator
US20060013855A1 (en) * 2004-04-05 2006-01-19 Medivas, Llc Bioactive stents for type II diabetics and methods for use thereof
US20060025857A1 (en) * 2004-04-23 2006-02-02 Bjarne Bergheim Implantable prosthetic valve
US20060025855A1 (en) * 2004-05-05 2006-02-02 Lashinski Randall T Translumenally implantable heart valve with multiple chamber formed in place support
US20060025854A1 (en) * 2004-05-05 2006-02-02 Lashinski Randall T Translumenally implantable heart valve with formed in place support
US20060020334A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Methods of cardiac valve replacement using nonstented prosthetic valve
US20060020332A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Nonstented temporary valve for cardiovascular therapy
US20060020327A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Nonstented heart valves with formed in situ support
US20060004439A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Device and method for assisting in the implantation of a prosthetic valve
US20060004442A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Paravalvular leak detection, sealing, and prevention
US20060030747A1 (en) * 2004-07-09 2006-02-09 Kantrowitz Allen B Synchronization system between aortic valve and cardiac assist device
US20060009804A1 (en) * 2004-07-12 2006-01-12 Pederson Brian D Anti-coagulation and demineralization system for conductive medical devices
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US20060015179A1 (en) * 2004-07-19 2006-01-19 Neil Bulman-Fleming Aortic annuloplasty ring

Also Published As

Publication number Publication date
JP4388821B2 (en) 2009-12-24
AU2003226217A1 (en) 2003-10-20
EP1489997A1 (en) 2004-12-29
CA2480876A1 (en) 2003-10-16
US20030191479A1 (en) 2003-10-09
US7007698B2 (en) 2006-03-07
JP2005521515A (en) 2005-07-21
WO2003084442A1 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
US7007698B2 (en) Body lumen closure
US11564818B2 (en) Vascular implant
AU723785B2 (en) Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
US10376364B2 (en) Implant delivery capsule
US6425915B1 (en) Helical mesh endoprosthesis and methods of use
US5824053A (en) Helical mesh endoprosthesis and methods of use
US6602280B2 (en) Delivery system and method for expandable intracorporeal device
US5836965A (en) Stent delivery and deployment method
US6660032B2 (en) Expandable coil endoluminal prosthesis
CN108378960B (en) Adjustable bend conveying system of interventional heart valve
EP1653882B1 (en) Clutch driven stent delivery system
US20080114391A1 (en) Aneurysm covering devices and delivery devices
US10932932B2 (en) Delivery device with an expandable positioner for positioning a prosthesis
US20070173924A1 (en) Axially-elongating stent and method of deployment
JP7150920B2 (en) Stent graft device having anchor members with adjustable geometry
US8784439B1 (en) Percutaneous medical procedures and devices for closing vessels using mechanical closures
WO2008148385A1 (en) A stent

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION